109
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Distinct Antimicrobial Resistance Profiling Of Clinically Important Aeromonas Spp. In Southwest China: A Seven-Year Surveillance Study

ORCID Icon, , &
Pages 2971-2978 | Published online: 18 Sep 2019

References

  • Janda JM, Abbott SL. The genus Aeromonas: taxonomy, pathogenicity, and infection. Clin Microbiol Rev. 2010;23(1):35–73. doi:10.1128/CMR.00039-0920065325
  • Chen PL, Lamy B, Ko WC. Aeromonas dhakensis, an Increasingly Recognized Human Pathogen. Front Microbiol. 2016;7:793. doi:10.3389/fmicb.2016.0079327303382
  • Batra P, Mathur P, Misra MC. Aeromonas spp. an emerging nosocomial pathogen. J Lab Physicians. 2016;8(1):1–4.27013806
  • Ghenghesh KS, Rahouma A, Zorgani A, Tawil K, Al Tomi A, Franka E. Aeromonas in Arab countries: 1995–2014. Comp Immunol Microbiol Infect Dis. 2015;42:8–14. doi:10.1016/j.cimid.2015.07.00226577192
  • Igbinosa IH, Igumbor EU, Aghdasi F, Tom M, Okoh AI. Emerging Aeromonas species infections and their significance in public health. Sci World J. 2012;2012:625023. doi:10.1100/2012/625023
  • (CLSI), C.L.S.I. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated of fastidious bacteria. CLSI document M45-A3. Wayne: CLSI; 2015.
  • Didelot X, Walker AS, Peto TE, Crook DW, Wilson DJ. Within-host evolution of bacterial pathogens. Nat Rev Microbiol. 2016;14(3):150–162. doi:10.1038/nrmicro.2015.1326806595
  • Spengler G, Kincses A, Gajdács M, Amaral L. New roads leading to old destinations: efflux pumps as targets to reverse multidrug resistance in bacteria. Molecules. 2017;22(3):468. doi:10.3390/molecules22030468
  • Castelo-Branco Dde S, Guedes GM, Brilhante RS, et al. Virulence and antimicrobial susceptibility of clinical and environmental strains of Aeromonas spp. from northeastern Brazil. Can J Microbiol. 2015;61(8):597–601. doi:10.1139/cjm-2015-010726103449
  • McAuliffe GN, Hennessy J, Baird RW. Relative frequency, characteristics, and antimicrobial susceptibility patterns of Vibrio spp., Aeromonas spp., Chromobacterium violaceum, and Shewanella spp. in the northern territory of Australia, 2000–2013. Am J Trop Med Hyg. 2015;92(3):605–610. doi:10.4269/ajtmh.14-071525548380
  • Bargui H, Marzouk M, Benhadj A, Hadj Ali M, Ben Salem Y, Boukadida J. Aeromonas spp. human infection: retrospective study in the region of sousse, 2011–2015. Tunis Med. 2017;5(4):257–261.
  • Bhaskar M, Dinoop KP, Mandal J. Characterization of ceftriaxone-resistant Aeromonas spp. isolates from stool samples of both children and adults in Southern India. J Health Popul Nutr. 2015;33:26. doi:10.1186/s41043-015-0036-726825984
  • Rhee JY, Jung DS, Peck KR. Clinical and therapeutic implications of Aeromonas Bacteremia: 14 years nation-wide experiences in Korea. Infect Chemother. 2016;48(4):274–284. doi:10.3947/ic.2016.48.4.27428032485
  • Tang HJ, Lai CC, Lin HL, Chao CM. Clinical manifestations of bacteremia caused by Aeromonas species in southern Taiwan. PLoS One. 2014;9(3):e91642. doi:10.1371/journal.pone.009164224614100
  • Zhou Y, Yu L, Nan Z, et al. Taxonomy, virulence genes and antimicrobial resistance of Aeromonas isolated from extra-intestinal and intestinal infections. BMC Infect Dis. 2019;19(1):158. doi:10.1186/s12879-019-3766-030764764
  • Gajdács M, Urbán E. Resistance trends and epidemiology of citrobacter-enterobacter-serratia in urinary tractinfections of inpatients and outpatients (RECESUTI): a 10-year survey. Medicina (Kaunas). 2019;55(6):285.
  • Gajdács M, Urbán E. Epidemiological trends and resistance associated with Stenotrophomonas maltophilia Bacteremia: a 10-year retrospective cohort study in a tertiary-care hospital in hungary. Diseases. 2019;7(2):41. doi:10.3390/diseases7020041
  • (CLSI), C.L.S.I. Analysis and presentation of cumulative antimicrobial susceptibility test data: 4th approved guideline. CLSI document M39-A4. Wayne: CLSI; 2014.
  • Parker JL, Shaw JG. Aeromonas spp. clinical microbiology and disease. J Infect. 2011;62(2):109–118. doi:10.1016/j.jinf.2010.12.00321163298
  • Lamy B, Kodjo A, Col BVH Study Group, Laurent F. Prospective nationwide study of Aeromonas infections in France. J Clin Microbiol. 2009;47(4):1234–1237. doi:10.1128/JCM.00155-0919244464
  • Chao CM, Lai CC, Tsai HY, et al. Pneumonia caused by Aeromonas species in Taiwan, 2004–2011. Eur J Clin Microbiol Infect Dis. 2013;32(8):1069–1075. doi:10.1007/s10096-013-1852-623474673
  • Nolla-Salas J, Codina-Calero J, Valles-Angulo S, et al. Clinical significance and outcome of Aeromonas spp. infections among 204 adult patients. Eur J Clin Microbiol Infect Dis. 2017;36(8):1393–1403. doi:10.1007/s10096-017-2945-428258303
  • Zhang C, Xu X, Pu S, et al. Characterization of carbapenemases, extended spectrum β-lactamases, quinolone resistance and aminoglycoside resistance determinants in carbapenem-non-susceptible Escherichia coli from a teaching hospital in Chongqing, Southwest China. Infect Genet Evol. 2014;27:271–276. doi:10.1016/j.meegid.2014.07.03125107431
  • Yang P, Chen Y, Jiang S, Shen P, Lu X, Xiao Y. Association between antibiotic consumption and the rate of carbapenem-resistant Gram-negative bacteria from China based on 153 tertiary hospitals data in 2014. Antimicrob Resist Infect Control. 2018;7:137. doi:10.1186/s13756-018-0430-130479750
  • Arega B, Wolde-Amanuel Y, Adane K, Belay E, Abubeker A, Asrat D. Rare bacterial isolates causing bloodstream infections in Ethiopian patients with cancer. Infect Agent Cancer. 2017;12:40. doi:10.1186/s13027-017-0150-928702079
  • Kimura M, Araoka H, Yoneyama A. Aeromonas caviae is the most frequent pathogen amongst cases of Aeromonas bacteremia in Japan. Scand J Infect Dis. 2013;45(4):304–309. doi:10.3109/00365548.2012.73747423163893
  • Adler A, Assous MV, Paikin S, et al. Emergence of VIM producing Aeromonas caviae in Israeli hospitals. J Antimicrob Chemother. 2014;69(5):1211–1214. doi:10.1093/jac/dkt50524390932
  • Anandan S, Gopi R, Devanga Ragupathi NK, et al. First report of blaOXA-181-mediated carbapenem resistance in Aer- omonas caviae in association with pKP3-A: threat for rapid dissemination. J Glob Antimicrob Resist. 2017;10:310–314. doi:10.1016/j.jgar.2017.07.00628743649
  • Hughes HY, Conlan SP, Lau AF, et al. Detection and whole-genome sequencing of carbapenemase-producing Aeromonas hydrophila isolates from routine perirectal surveillance culture. J Clin Microbiol. 2016;54(4):1167–1170. doi:10.1128/JCM.03229-1526888898
  • Sinclair HA, Heney C, Sidjabat HE, et al. Genotypic and phenotypic identification of Aeromonas species and CphA-mediated carbapenem resistance in Queensland, Australia. Diagn Microbiol Infect Dis. 2016;85(1):98–101. doi:10.1016/j.diagmicrobio.2016.02.00526971634
  • Soltan Dallal MM, Mazaheri Nezhad Fard R, Kavan Talkhabi M, Aghaiyan L, Salehipour Z. Prevalence, virulence and antimicrobial resistance patterns of Aeromonas spp. isolated from children with diarrhea. GERMS. 2016;6(3):91–96. doi:10.11599/germs.2016.109427622161
  • Li F, Wang W, Zhu Z, et al. Distribution, virulence-associated genes and antimicrobial resistance of Aeromonas isolates from diarrheal patients and water, China. J Infect. 2015;70(6):600–608. doi:10.1016/j.jinf.2014.11.00425447712
  • Wen Y, Pu X, Zheng W, Hu G. High prevalence of plasmid-mediated quinolone resistance and IncQ plasmids carrying qnrS2 gene in bacteria from rivers near hospitals and aquaculture in China. PLoS One. 2016;11(7):e0159418. doi:10.1371/journal.pone.015941827427763
  • Varshney A, Das M, Chaudhary P, Kumari R, Yadav K. Aeromonas Salmonicida as a causative agent for postoperative endophthalmitis. Middle East Afr J Ophthalmol. 2017;24(4):213–215. doi:10.4103/meajo.MEAJO_238_1729422757
  • Moore CA, Khalid MF, Patel PD, Goldstein JS. Aeromonas Salmonicida Bacteremia associated with chronic well water consumption in a patient with diabetes. J Glob Infect Dis. 2017;9(2):82–84.28584462
  • Vincent AT, Fernandez-Bravo A, Sanchis M, Mayayo E, Figueras MJ, Charette SJ. Investigation of the virulence and genomics of Aeromonas salmonicida strains isolated from human patients. Infect Genet Evol. 2019;68:1–9. doi:10.1016/j.meegid.2018.11.01930502493
  • Ye Y, Xu XH, Li JB. Emergence of CTX-M-3, TEM-1 and a new plasmid-mediated MOX-4 AmpC in a multiresistant Aeromonas caviae isolate from a patient with pneumonia. J Med Microbiol. 2010;59(Pt 7):843–847. doi:10.1099/jmm.0.016337-020339022
  • Liu YM, Chen YS, Toh HS, et al. In vitro susceptibilities of non Enterobacteriaceae isolates from patients with intra-abdominal infections in the Asia-Pacific region from 2003 to 2010: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). Int J Antimicrob Agents. 2012;40 Suppl:S11–S17. doi:10.1016/S0924-8579(12)70004-322749053